Biostar Pharmaceuticals, Inc. Proceeds from Short-term Debt
Biostar Pharmaceuticals, Inc. reported Proceeds from Short-term Debt of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2016-04-14
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for the quarter ending 2011-12-31 was $4.46K.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for the quarter ending 2011-09-30 was $9.02K.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for the quarter ending 2011-06-30 was $315.63K.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for the quarter ending 2011-03-31 was $458.01K.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for fiscal 2014 was $3.25M.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Biostar Pharmaceuticals, Inc. proceeds from short-term debt for fiscal 2012 was $4.75M, a 503.87% increase from fiscal 2011.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 6 month | Proceeds from Short-term Debt 9 month | Proceeds from Short-term Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-04-14 | |||
| 2014-12-31 | $3.25M 10-K · filed 2016-04-14 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-04-15 | |||
| 2012-12-31 | $4.75M 10-K · filed 2014-03-31 | |||
| 2012-06-30 | -$791.18K 10-Q · filed 2012-08-14 | |||
| 2011-12-31 | $4.46K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $13.48K derived: sum of 2 quarters · filed 2013-04-15 | $329.11K derived: sum of 3 quarters · filed 2013-04-15 | $787.12K 10-K · filed 2013-04-15 |
| 2011-09-30 | $9.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | $324.65K derived: sum of 2 quarters · filed 2012-11-19 | $782.66K 10-Q · filed 2012-11-19 | |
| 2011-06-30 | $315.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $773.63K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $458.01K 10-Q · filed 2012-05-15 |